Pre-Mix Insulin Lispro Treatment for Type 2 Diabetes Patients Who Consume a Light Breakfast

NCT00664534 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

344

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Insulin Glargine
DRUG: Insulin Lispro Premix (mid-mixture and low-mixture)

Sponsor

Eli Lilly and Company